The behavioral profile of spice and synthetic cannabinoids in humans

被引:24
|
作者
Mueller, Helge H. [1 ,2 ]
Kornhuber, Johannes [1 ]
Sperling, Wolfgang [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nuremberg, Dept Psychiat & Psychotherapy, Erlangen, Germany
[2] Med Campus Univ Oldenburg, Univ Hosp, Sch Med & Hlth Sci, Dept Psychiat & Psychotherapy,Karl Jaspers Klin, Hermann Ehlers Str 7, D-26160 Bad Zwischenahn, Germany
关键词
Synthetic cannabinoids; Spice; Neuropsychiatric side-effects; Somatic effects; Treatment; HIGH-POTENCY CANNABIS; MASS-SPECTROMETRY; DESIGNER DRUGS; LEGAL HIGHS; CASE SERIES; PSYCHOSIS; ABUSE; JWH-018; K2; IDENTIFICATION;
D O I
10.1016/j.brainresbull.2015.10.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The use of synthetic cannabinoids (spice) is increasing. The number of descriptions of (new) clinical side effects is also increasing. We screened relevant publications for articles about spice with a focus on the clinical manifestations of the use of this drug. Spice creates diffuse psychiatric and somatic effects that are only partially similar to those of natural cannabinoids. Most of the observed effects are related to sympathomimetic-cardiac effects and neuropsychiatric manifestations. Clinical treatment is primarily based on intensive apparative and laboratory monitoring and supportive therapy. Because the exact active ingredients of spice are often difficult to determine with standard specific toxicology testing, the assessment and analysis of consumed substances by specialized laboratories is recommended. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 50 条
  • [31] Synthetic Cannabinoids
    Mills, Brooke
    Yepes, Andres
    Nugent, Kenneth
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (01): : 59 - 62
  • [32] Synthetic cannabinoids
    Bilici, Rabia
    NORTHERN CLINICS OF ISTANBUL, 2014, 1 (02) : 121 - 126
  • [33] SYNTHETIC CANNABINOIDS
    Camp, Nancy E.
    JOURNAL OF EMERGENCY NURSING, 2011, 37 (03) : 292 - 293
  • [34] SYNTHETIC CANNABINOIDS
    Boulanger, William
    CHEMICAL & ENGINEERING NEWS, 2011, 89 (05) : 6 - 6
  • [35] Cannabinoids and psychosis: Behavioral, cognitive and electrophysiological evidence from laboratory studies in humans
    D'Souza, Deepak Cyril
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 153S - 154S
  • [36] Pharmacological evaluation of new constituents of “Spice”: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds
    Clara T. Schoeder
    Cornelius Hess
    Burkhard Madea
    Jens Meiler
    Christa E. Müller
    Forensic Toxicology, 2018, 36 : 385 - 403
  • [37] K2—Not the Spice of Life; Synthetic Cannabinoids and ST Elevation Myocardial Infarction: A Case Report
    McKeever R.G.
    Vearrier D.
    Jacobs D.
    LaSala G.
    Okaneku J.
    Greenberg M.I.
    Journal of Medical Toxicology, 2015, 11 (1) : 129 - 131
  • [38] A fast and inexpensive procedure for the isolation of synthetic cannabinoids from ‘Spice’ products using a flash chromatography system
    Bjoern Moosmann
    Stefan Kneisel
    Ariane Wohlfarth
    Volker Brecht
    Volker Auwärter
    Analytical and Bioanalytical Chemistry, 2013, 405 : 3929 - 3935
  • [39] Use of Venovenous Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage Due to Inhaled Synthetic Cannabinoids or "Spice"
    Patel, M.
    Tormoehlen, L. M.
    Gutteridge, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [40] K2-not the spice of life: Synthetic cannabinoids and ST elevation myocardial infarction: a case report
    Mckeever, Rita G.
    Vearrier, David
    Greenberg, Michael I.
    CLINICAL TOXICOLOGY, 2014, 52 (04) : 362 - 363